Down syndrome and Alzheimer’s disease: A scoping review of functional performance and fall risk
As with the general aging adult population, there is an urgent need to understand the preclinical and early phases of AD (Alzheimer disease) progression in the adult population with DS. The aim of this scoping review was to synthesize the current state of the evidence and identify gaps in the literature regarding functional activity performance
Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
Alzheimer’s disease is a multifactorial progressive neurodegenerative disorder characterized by memory loss, disorientation, and gradual decline in intellectual ability. The accumulation of beta-amyloid (Aβ) peptides is assessed to be one of the essential neuropathological pillars of the disorder, and its dishomeostasis plays an essential
Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial
Major depressive disorder impacts approximately 264 million people worldwide and is a leading cause of the global disability burden. In major depressive disorder (MDD), cognitive dysfunctions strongly contribute to functional